Medline, Inc. MDLN Effect of exchange rate changes on cash, cash equivalents and restricted cash

Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies

West Pharmaceutical ServicesWST

——

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$7.4B+10.7%

Gross profit$1.8B+0.9%

Operating income$422.0M-26.1%

Net income$239.0M-25.1%

EPS (diluted)$0.16—

Balance sheet

See full

Cash & equivalents$2.2B+166%

Total debt$12.6B—

Total equity$11.3B—

Total assets$39.0B—

Cash flow

See full

Operating cash flow$412.0M-39.6%

CapEx$96.0M-2.0%

Free cash flow$316.0M-45.9%

Valuation

See full

Market cap$30.39B—

Enterprise value$40.71B—

P/E36.1×—

P/S1.1×—

Profitability

See full

Gross margin27.4%+1.5pp

Operating margin8.5%+2.3pp

Net margin4.6%+2.7pp

Returns & leverage

See full

Return on equity7.7%—

Debt / equity1.1×—

Current ratio4.4×—

Where this comes from

Reported directly by Medline, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's effect of exchange rate changes on cash, cash equivalents and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medline, Inc. 's effect of exchange rate changes on cash, cash equivalents and restricted cash?: Medline, Inc. (MDLN) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$7M in Q1 2026.
How has Medline, Inc. 's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?: Medline, Inc. 's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 177.8% year-over-year, from $9M to -$7M.